NYSE: DVA
DaVita Inc.
Healthcare · Medical - Care Facilities
After hours: $176.70(0%) · as of 7:49 PM ET
Market Cap
$11.34B
52w High
$247.49
52w Low
$101.00
P/E
13.78
Volume
373.11K
Outstanding Shares
64.20M
Valuation Data Insufficient
The DCF model's fair value estimate is more than 3× the current stock price. This typically indicates unreliable model inputs — such as irregular cash flows or balance sheet distortions — rather than a genuine opportunity, so the valuation is not shown.
Performance
Return analysis
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 32.61% over the last year. Revenue grew 6.45% over the trailing twelve months. Operating margin moved from 15.78% to 15.06%. Free cash flow grew 24.94% over the trailing twelve months.
What the market seems to be pricing
The stock move broadly lines up with stronger business momentum, and the shares are still only around the 28th percentile of their historical P/FCF range.
What would invalidate this read
Operating margin is at 15.06%. Revenue grew 6.45% — this thesis depends on that trajectory holding. If revenue growth, margins, or free cash flow roll over while the stock keeps climbing, more of the move would be coming from multiple expansion than business progress.
Company profile
DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure.
Valuation
Stock splits
Every 1 shares became 2
Every 2 shares became 3
Every 3 shares became 5
Profitability & growth
Analyst consensus
10
Buy
12
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Oct 28, 2026
Q4 FY26 · EPS est $3.68 · Revenue est $3.51B
View